1. Adherence with and completion of recommended hepatitis vaccination schedules among adults in the United States. Issue 35 (23rd August 2018) Authors: Trantham, Laurel; Kurosky, Samantha K.; Zhang, Dongmu; Johnson, Kelly D. Journal: Vaccine Issue: Volume 36:Issue 35(2018) Page Start: 5333 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical and economic burden of pneumococcal disease among individuals aged 16 years and older in Germany. (8th November 2022) Authors: Deb, Arijita; Podmore, Bélène; Barnett, Rosemarie; Beier, Dominik; Galetzka, Wolfgang; Qizilbash, Nawab; Haeckl, Dennis; Mihm, Sarah; Johnson, Kelly D.; Weiss, Thomas Journal: Epidemiology and infection Issue: Volume 150(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cost and health impact analysis of herpes zoster vaccination in Norway. (17th February 2022) Authors: Flem, Elmira; Graham, Jonathan; Yi, Zinan; Wisløff, Torbjørn; Johnson, Kelly D. Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 22:Number 2(2022) Page Start: 315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cost-effectiveness of the 15-valent pneumococcal conjugate vaccine for high-risk adults in Switzerland. (4th May 2022) Authors: Deb, Arijita; Guggisberg, Patrik; Mutschler, Thomas; Owusu-Edusei, Kwame; Bencina, Goran; Johnson, Kelly D.; Ignacio, Tim; Mathijssen, Daan A.R.; Qendri, Venetia Journal: Expert review of vaccines Issue: Volume 21:Number 5(2022) Page Start: 711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Economic Burden of Herpes Zoster ("culebrilla") in Latin America. (May 2017) Authors: Rampakakis, Emmanouil; Pollock, Clare; Vujacich, Claudia; Toniolo Neto, Joao; Ortiz Covarrubias, Alejandro; Monsanto, Homero; Johnson, Kelly D. Journal: International journal of infectious diseases Issue: Volume 58(2017:May) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence. (4th March 2021) Authors: Niederman, Michael S.; Folaranmi, Temitope; Buchwald, Ulrike K.; Musey, Luwy; Cripps, Allan W.; Johnson, Kelly D. Journal: Expert review of vaccines Issue: Volume 20:Number 3(2021) Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Health economic evaluation of introducing a PPSV23-based vaccination programme to adults aged 65 and above, and an extension to the 60-64 age group in Denmark. (3rd October 2021) Authors: Birck, Anders Muusfeldt; Nordin Christensen, Liv; Pedersen, Mikkel H.; Olsen, Jens; Johnson, Kelly D.; Bencina, Goran; Clausen, Thomas Holtkøtter; Larsen, Carsten Schade Journal: Expert review of vaccines Issue: Volume 20:Number 10(2021) Page Start: 1327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of pneumococcal disease: a review of the literature. (4th March 2021) Authors: Cripps, Allan W.; Folaranmi, Temitope; Johnson, Kelly D.; Musey, Luwy; Niederman, Michael S.; Buchwald, Ulrike K. Journal: Expert review of vaccines Issue: Volume 20:Number 3(2021) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pneumococcal vaccination coverage among adults newly diagnosed with underlying medical conditions and regional variation in the U.S. Issue 33 (5th August 2022) Authors: Ostropolets, Anna; Shoener Dunham, Linda; Johnson, Kelly D.; Liu, Junqing Journal: Vaccine Issue: Volume 40:Issue 33(2022) Page Start: 4856 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Regional factors associated with pneumococcal vaccination coverage among U.S. adults with underlying chronic or immunocompromising conditions. Issue 1 (31st December 2023) Authors: Liu, Junqing; Shoener Dunham, Linda; Johnson, Kelly D. Journal: Human vaccines & immunotherapeutics Issue: Volume 19:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗